Review

Effects of SGLT2 inhibitors on gout-related and cardiometabolic outcomes in patients with type 2 diabetes mellitus: a scoping review

Figure 1 from Advances in Rheumatology
Open the figure at full size
Figure 1Sampaio et al.

Advances in Rheumatology

The paper

Universidade Sagrado Coração · Universidade de São Paulo

Advances in Rheumatology · 24 Jul 2026

doi.org/10.1186/s42358-026-00564-wPubMed 42823726

More on SGLT2 inhibitors